The response to a range of small doses of suxamethonium was evaluated in a patient with an atypical plasma cholinesterase who required a course of electroconvulsive therapy. A dose of 0.05-0.1 mg/kg of suxamethonium is suggested as a suitable test dose in patients suspected of having an atypical plasma cholinesterase.
PantuckE.J., PantuckC.B.Cholinesterases and anticholinesterases. In: Muscle Relaxants, Excerpta Medica1975; 156–159.
2.
WhittakerM.Plasma cholinesterase variants and the anaesthetist. Anaesthesia1980; 35: 174–197.
3.
SchuhF.T.Serum cholinesterase: effect on the action of suxamethonium following administration to a patient with cholinesterase deficiency. Br J Anaesth1977; 49: 269–272.
4.
KatzR.L., KatzG.J.Clinical considerations in the use of muscle relaxants. In: Muscle Relaxants, Excerpta Medica1975; 318.
5.
AliH.H., SavareseJ.J.Monitoring of neuromuscular function. Anesthesiology1976; 45: 216–249.
6.
CohenP.J., ReynoldsR.C., NaidlJ.A simple test for abnormal pseudocholinesterase. Anesthesiology1970; 32: 281–282.
7.
BarakaA.Hexafluorenium-suxamethonium interaction in patients with normal versus atypical cholinesterase. Br J Anaesth1975; 47: 885–888.
8.
Lee-SonS., PilonR.N., NahorA., WaudB.E.Use of succinylcholine in the presence of atypical cholinesterase. Anesthesiology1975; 43: 493–496.
9.
KatzR.L.Electromyographic and mechanical effects of suxamethonium and tubocurarine on twitch, tetanic and post-tetanic responses. Br J Anaesth1973; 45: 849–859.
10.
ShanksC., JarvisJ.E.Electromyographic and mechanical twitch responses following suxamethonium administration. Anaesth Intens Care1980; 8: 341–344.